Ellen Zhang

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review”.

Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review

Thrombosis Research(2023)10.1016/j.thromres.2023.04.017

N/A

0.493DataRank · unranked

13 citations

Zain M. Virk, Josanna Rodriguez‐Lopez, Hanny Al-Samkari, Ellen Zhang

Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia

Journal of Thrombosis and Haemostasis(2023)10.1016/j.jtha.2022.09.003

N/A

0DataRank · unranked

13 citations

Ellen Zhang, Josanna Rodriguez‐Lopez, Alison S. Witkin, Alexandra K. Wong, Jay Luther +6 more

Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia

Blood Advances(2024)10.1182/bloodadvances.2024012589

N/A

0DataRank · unranked

7 citations

Satoko Ito, Christina Waldron, Ayesha Butt, Ellen Zhang, Harlan M. Krumholz +3 more